Dr. Aaron Kesselheim (MD, JD, MPH) created and leads the Brigham and Women’s Hospital’s Program On Regulation, Therapeutics, And Law (PORTAL). He recently testified to Congress (click to watch testimony) regarding the 2022 Inflation Reduction Act’s provisions for prescription drugs, including new mechanisms enabling the government to negotiate drug prices.

Please join us for a casual discussion on these policies, how they’re shaping the drugmaking industry, and their potential impact on healthcare innovation, access, and quality.